| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 2875 | alpha-L-FEAU |
2875.0002: 2 mg per vial 2875.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Analytical standard for validation of [11C]L-FEAU and [18F]L-FEAU synthesis (2′-[18F]Fluoro-5-ethyl-1-α-L-arabinofuranosyluracil) |
||
| Molar Mass: 274.25 | ||
| C11H15FN2O5 | ||
| CAS-RN not yet assigned | ||
| Colourless solid/foam packaged in dark glass crimp cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 19F NMR spectra |
||
|
Chemical Name: CA index name: 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-2-fluoro-α-L-arabinofuranosyl)-5-ethyl- |
||
|
Synonymes: 1-(2-Deoxy-2-fluoro-α-L-arabinofuranosyl)-5-ethyluracil; 1-(2-Deoxy-2-fluoro-α-L-arabinofuranosyl)-5-ethyl-2,4(1H,3H)-pyrimidinedione; 2′-Fluoro-5-ethyl-α-L-arabinofuranosyluracil; 5-Ethyl-1-(2-fluoro-2-deoxy-α-L-arabinofuranosyl)uracil; 1-(2-Deoxy-2-fluoro-α-L-arabinofuranosyl)-5-ethyl-2,4(1H,3H)-pyrimidinedione; α-L-FEAU |
||
|
Literature: 1. Ma et al. Structure-Activity Relationships of 1-(2-Deoxy-2-fluoro-β-l-arabino-furanosyl)pyrimidine Nucleosides as Anti-Hepatitis B Virus Agents. J. Med. Chem. 1996, 39, 2835-2843. |
||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1